Plasma thioredoxin level and its correlation to myocardial damage in patients with acute myocardial infarction who underwent successful primary angioplasty

Korean Circulation Journal

Volumn 36, Issue 1, 2006, Pages 39-45

  Kim, Ki Seok ^b   Han, Hyeo Sook ^a   Lee, Yeong Shin ^a   Bae, Jang Whan ^a   Hwang, Kyeong Kuk ^a   Kim, Dong Woon ^a   Joo, Seung Jae ^b   Cho, Myeong Chan ^a  

^a Chungbuk National University   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Angioplasty; Myocardial infarction; Oxidative stress; Thioredoxin

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; THIOREDOXIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MALE; OXIDATIVE STRESS; PLASMA; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 33644596813     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.1.39     Document Type: Article

References (27)

1. Nordberg J, Amer ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-312.
2. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxid Redox Signal 2002;4:405-14.
3. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-69.
4. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation: the two keystones of ischemia/reperfusion injury. Int J Cardiol 2002;86:41-59.
5. Miyamoto M, Kishimoto C, Shioji K, et al. Difference in thioredoxin expression in viral myocarditis in inbred strains of mice. Jpn Circ J 2001;65:561-4.
6. Miyamoto M, Kishimoto C, Shioji K, et al. Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ J 2003;67:116-8.
7. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 2001;65:491-4.
8. Shioji K, Matsuura Y, Iwase T, et al. Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report. Circ J 2002;66:977-80.
9. Hokamaki J, Kawano H, Soejima H, et al. Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol 2005;99:225-31.
10. Soejima H, Suefuji H, Miyamoto S, et al. Increased plasma thioredoxin in patients with acute myocardial infarction. Clin Cardiol 2003;26:583-7.
11. Jun JE, Chun BY, Choi YS, et al. Effects of antioxidant supplementation on the lipid peroxidation and antioxidative enzyme activities in patients with coronary heart disease. Korean Circ J 2001;31:1215-24.
12. Cho YS, Choi JH, Zhang SY, et al. Relationship of polymorphisms in the oxidative stress related genes: paraoxonase and p22phox- to variant angina and coronary artery stenosis in Korean. Korean Circ J 2003;33:104-12.
13. Kakisaka Y, Nakashima T, Sumida Y, et al. Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horn Metab Res 2002;34:160-4.
14. Miwa K, Kishimoto C, Nakamura H, et al. Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors. Circ J 2005;69:291-4.
15. Yamawaki H, Haendeler J, Berk BC. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res 2003;93:1029-33.
16. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002;192:1-15.
17. Jekell A, Hossain A, Alehagen U, Dahlstrom U, Rosen A. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail 2004;6:883-90.
18. Guan W, Osanai T, Kamada T, Ishizaka H, Kanada H, Okumura K. Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn Circ J 1999;63:924-8.
19. Ide T, Tsutsui H, Kinugawa S, et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 2000;86:152-7.
20. Tsutsui H, Ide T, Hayashidani S, et al. Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 2001;104:134-6.
21. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44:1945-56.
22. Han J, Hong ES, Yoon SI, et al. The relationship between initial leukocyte count and the extent of myocardial injury in patients with acute myocardial infarction who received reperfusion therapy. Korean Circ J 2004;34:735-42.
23. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000;102:2329-34.
24. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-70.
25. Turoczi T, Chang VW, Engelman RM, Maulik N, Ho YS, Das DK. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol 2003;35:695-704.
26. Das DK, Maulik N. Preconditioning potentiates redox signaling and converts death signal into survival signal. Arch Biochem Biophys 2003;420:305-11.
27. Marczin N, el-Habashi N, Hoare GS, Bundy RE, Yacoub M. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys 2003;420:222-36.